Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Antibiotics vs Probiotics in Periodontitis Treatment
NCT07592416Phase 1Completed
- Sponsor
- Universidade de São Paulo
- Start
- Aug 2023
- Primary completion
- Jan 2026
- Modality
- Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of bifidobacterium animalis subsp lactis HN019 in periodontitis (3 arms), sponsored by Universidade de São Paulo. Primary endpoints: Periodontal Probing Depth at 12 months, Clinical Attachment Level at 12 months and 4 more. Started Aug 2023; status: completed.
02
Drugs
bifidobacterium animalis subsp lactis HN019
03
Conditions
periodontitis
Beyond the preview
Go deeper on NCT07592416.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07592416.